To what extent will the introduction of the C-Reactive Protein (CRP) point of care test and enhanced communication skills for managing lower respiratory tract infection (LRTI) in general practice, either separately or combined, lead to 1. an…
Bron
Verkorte titel
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Change (decrease) in antibiotic prescription; <br>
2. Clinical recovery and return to normal work and activities.
Achtergrond van het onderzoek
Male and Female > 18 years old.
To what extent will the introduction of the C-Reactive Protein (CRP) point of care test and enhanced communication skills for managing lower respiratory tract infection (LRTI) in general practice, either separately or combined, lead to an enhancement of patient recovery, a reduction in other diagnostic testing, use of other medical services and a reduction in antibiotic prescribing? To what extent are these reductions cost-effective?
Study design: factorial design with randomisation on practice level. Control group follows pathways of usual care.
Doel van het onderzoek
To what extent will the introduction of the C-Reactive Protein (CRP) point of care test and enhanced communication skills for managing lower respiratory tract infection (LRTI) in general practice, either separately or combined, lead to
1. an enhancement of patient recovery,
2. a reduction in other diagnostic testing
3. and a reduction in antibiotic prescribing?
4. To what extent are these reductions cost-effective?
Onderzoeksproduct en/of interventie
Randomisation at the level of practice. Factorial randomisation into four groups:
1. Access to and training in PoC CRP plus communication training.
2. Access to and training in PoC CRP alone.
3. Communication training alone.
4. Usual care.
Point of Care CRP: Access to and training in use of automatic CRP test device.
Sample is one drop of whole blood from a finger prick.
Communication training: Shared decision making using SPICE method (Simulated Patient in Clinical Encounter).
Publiek
P.O. Box 616
Jochen Cals
Maastricht 6200 MD
The Netherlands
+31 (0)43 3882441
j.cals@hag.unimaas.nl
Wetenschappelijk
P.O. Box 616
Jochen Cals
Maastricht 6200 MD
The Netherlands
+31 (0)43 3882441
j.cals@hag.unimaas.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
First consultation of current episode of acute cough (duration <4 weeks).
Regarded by the GP to be caused by an acute lower respiratory tract infection
- At least one out of following 4: Shortness of breath / wheezing / chest pain / auscultation abnormalities
- At least one of the following 5:
Fever / perspiring / headache / myalgia / feeling generally unwell.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Patients who require immediate admission to hospital;
2.Patients who have no understanding of written and/or Dutch language;
3. Patients who previously participated in the study;
4. Patients who currently use antibiotic or have taken an antibiotic in the past 2 weeks;
5. Patients who have been hospitalized in the past 6 weeks.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL31 |
NTR-old | NTR51 |
Ander register | : N/A |
ISRCTN | ISRCTN85154857 |